Is Striverdi Respimat in shortage in 2026? Get the latest update on availability, pricing, and what COPD patients can do if they can't find it.
If you've been struggling to fill your Striverdi Respimat (Olodaterol) prescription lately, you're probably wondering: is there an official shortage? The short answer is that Striverdi Respimat is not currently listed on the FDA's drug shortage database as of early 2026. But that doesn't mean finding it at your pharmacy is easy.
Even without a formal shortage, many patients report difficulty locating Striverdi at their local pharmacy. This article breaks down the current state of Striverdi availability, why it can be hard to find, what it costs in 2026, and what you can do about it.
As of March 2026, the FDA has not declared an official shortage of Striverdi Respimat. The drug's manufacturer, Boehringer Ingelheim, continues to produce it, and there have been no significant supply disruptions reported at the national level.
However, "no official shortage" doesn't always match what patients experience at the pharmacy counter. Here's why:
So while Striverdi is being manufactured and distributed, it may not be sitting on the shelf at every pharmacy near you.
Several factors contribute to the difficulty patients face when trying to find Striverdi Respimat:
There is no FDA-approved generic version of Striverdi Respimat as of 2026. With only one manufacturer producing it, supply is limited to a single source. This makes the drug more vulnerable to distribution gaps compared to medications with multiple generic manufacturers.
Some major pharmacy benefit managers (PBMs) and insurance plans have removed Striverdi from their preferred drug lists in recent years. When fewer patients are prescribed a medication, pharmacies reduce or eliminate their stock. This creates a cycle: less demand leads to less stocking, which makes it harder for the patients who do need it to find it.
The COPD treatment landscape has been shifting toward combination inhalers that include a LABA plus a LAMA (long-acting muscarinic antagonist) or even triple-therapy inhalers. Products like Stiolto Respimat (Tiotropium/Olodaterol) and Trelegy Ellipta have gained market share, which means standalone LABA inhalers like Striverdi are prescribed less often.
For more on why Striverdi can be difficult to locate, see our detailed article: Why is Striverdi so hard to find?
The cost of Striverdi Respimat without insurance typically ranges from $275 to $400 for a one-month supply (one inhaler). Here's a breakdown of pricing options:
Boehringer Ingelheim has also participated in the $35 inhaler price cap initiative, which limits out-of-pocket costs for certain patients. For full details on saving money, read our guide: How to save money on Striverdi in 2026.
If Striverdi isn't available or isn't working for your situation, there are several alternatives worth discussing with your doctor:
Learn more about each of these options in our full guide: Alternatives to Striverdi.
If you want to stay on Striverdi, here's how to find it:
Medfinder lets you search for pharmacies near your zip code that currently have Striverdi Respimat in stock. It's free, fast, and saves you the hassle of calling around.
Independent pharmacies often have more flexibility in ordering specialty medications. If your usual chain pharmacy doesn't carry Striverdi, an independent pharmacy may be able to order it for you within 1-2 business days.
Check with your insurance plan to see if Striverdi is available through a mail-order pharmacy. This can be a convenient way to ensure a steady supply, especially for a 90-day fill.
For step-by-step instructions, read our article: How to find Striverdi in stock near you.
While there's no official Striverdi shortage in 2026, the reality for patients is more nuanced. Formulary exclusions, the lack of a generic, and a shift toward combination inhalers can all make Striverdi harder to find at your local pharmacy. The key is to stay proactive: use tools like Medfinder, explore independent and mail-order pharmacies, and keep the conversation going with your doctor about the best treatment plan for your COPD.
Your lungs don't take days off, and neither should your access to the medication you need.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
